CCBE1 antibody (AA 201-300)
Quick Overview for CCBE1 antibody (AA 201-300) (ABIN872842)
Target
See all CCBE1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 201-300
-
Cross-Reactivity
- Mouse
-
Predicted Reactivity
- Human,Rat,Dog,Pig,Horse
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human CCBE1
-
Isotype
- IgG
-
-
-
-
Application Notes
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
- CCBE1 (Collagen and Calcium Binding EGF Domains 1 (CCBE1))
-
Alternative Name
- CCBE1
-
Background
-
Synonyms: CCBE 1, ccbe1, CCBE1_HUMAN, Collagen and calcium binding EGF domain containing protein 1, Collagen and calcium binding EGF domains 1, Collagen and calcium-binding EGF domain-containing protein 1, Full of fluid protein homolog.
Background: This gene is thought to function in extracellular matrixremodeling and migration. It is predominantly expressed in theovary, but down regulated in ovarian cancer cell lines and primarycarcinomas, suggesting its role as a tumour suppressor. Mutationsin this gene have been associated with Hennekamlymphangiectasia-lymphedema syndrome, a generalized lymphaticdysplasia in humans. [provided by RefSeq, Mar 2010].
-
Gene ID
- 147372
Target
-